Search

Search Constraints

You searched for: Author/Creator Taki, Masashi

Search Results

2. Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial. Issue 2 (17th February 2022)

4. Clinical conditions and risk factors for inhibitor‐development in patients with haemophilia: A decade‐long prospective cohort study in Japan, J‐HIS2 (Japan Hemophilia Inhibitor Study 2). Issue 5 (11th June 2022)

5. INF2 mutations in Charcot‐Marie‐Tooth disease complicated with focal segmental glomerulosclerosis. Issue 1 (22nd March 2013)

6. Long‐term safety and efficacy of emicizumab for up to 5.8 years and patients' perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A. Issue 1 (24th November 2020)

10. Successful living‐related kidney transplantation in a boy with inherited dysfibrinogenemia. (21st August 2013)